| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/16/2003 | EP1301500A1 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 04/16/2003 | EP1301493A2 Heterocycle carboxamides as antiviral agents |
| 04/16/2003 | EP1301487A2 Viral polymerase inhibitors |
| 04/16/2003 | EP1301486A2 Imidazolidinones as ns3-serine protease inhibitors of hepatitis c virus |
| 04/16/2003 | EP1301481A1 Pyrrole derivatives for treating aids |
| 04/16/2003 | EP1301480A1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 04/16/2003 | EP1301472A2 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 04/16/2003 | EP1301467A2 9-substituted minocycline compounds |
| 04/16/2003 | EP1301466A2 7-substituted tetracycline compounds |
| 04/16/2003 | EP1301465A2 13-substituted methacycline compounds |
| 04/16/2003 | EP1301211A2 Multifunctional nanodevice platform |
| 04/16/2003 | EP1301207A2 Compositions for treating bacterial infections, containing an oxazolidinone compound, sulbactam and and ampicillin |
| 04/16/2003 | EP1301204A1 Immunological combinations for prophylaxis and therapy of helicobacter pylori infection |
| 04/16/2003 | EP1301194A1 Essential oil combination and therapeutic uses thereof |
| 04/16/2003 | EP1301191A1 Potent immunostimulants from microalgae |
| 04/16/2003 | EP1301173A1 A medicinal aerosol formulation |
| 04/16/2003 | EP1301150A1 Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections |
| 04/16/2003 | EP1301074A2 Uses for nad synthetase inhibitors |
| 04/16/2003 | EP1181047B1 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 04/16/2003 | EP1150981B1 Use of (1r, 4s)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol in hbv |
| 04/16/2003 | EP1083901B1 Efavirenz compressed tablet formulation |
| 04/16/2003 | EP1051156B1 Pharmaceutical compositions |
| 04/16/2003 | EP1040095B1 Cyclohexene carboxylates as neuraminidase inhibitors |
| 04/16/2003 | EP0871632B1 Production of a crystalline salt of amoxicillin |
| 04/16/2003 | EP0868522B1 Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them |
| 04/16/2003 | EP0861032B1 Aquatic animal treatment method and composition containing cajeput oil |
| 04/16/2003 | EP0824544B1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use |
| 04/16/2003 | EP0674634B1 Process for preparing substituted 1,3-oxathiolanes with antiviral properties |
| 04/16/2003 | EP0648127B1 Type i surface antigens associated with staphylococcus epidermidis |
| 04/16/2003 | CN1411512A Chimeric immunogenic compositions and nucleir acids encoding them |
| 04/16/2003 | CN1411505A Membrane virus host range mutations and their uses as vaccine stroma |
| 04/16/2003 | CN1411468A Attenuated microorganisms for treatment of infection |
| 04/16/2003 | CN1411467A Compounds and use thereof to modify transport across cell membranes |
| 04/16/2003 | CN1411465A Method for preparing and isolating 9-deoxo-9 (Z)-hydroxyiminoerythromycin A |
| 04/16/2003 | CN1411458A Saccharin derivatives as orally active elastase inhibitors |
| 04/16/2003 | CN1411456A Chemokine receptor binding heterocyclic compounds |
| 04/16/2003 | CN1411450A Method for production of triazolinethione derivative |
| 04/16/2003 | CN1411449A N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
| 04/16/2003 | CN1411447A Polymorphic crystalline forms of celecoxib |
| 04/16/2003 | CN1411446A Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
| 04/16/2003 | CN1411445A Method for preparing 3-hydroxypicolinic acid derivatives |
| 04/16/2003 | CN1411380A Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine |
| 04/16/2003 | CN1411376A Novel helicobacter pylori-binding substances and use thereof |
| 04/16/2003 | CN1411372A Antimicrobial compositions comprising pyroglutamic acid and optionally metal salts |
| 04/16/2003 | CN1411339A Antimicrobial composition comprising benzoic acid analog and metal salt |
| 04/16/2003 | CN1410538A Production and use of high expression, high purity, high activity gene recombinant human lysozyme |
| 04/16/2003 | CN1410448A Terminal blocked pentahelicoprotein and its use |
| 04/16/2003 | CN1410419A Method and composition for treating or preventing bacterial infection |
| 04/16/2003 | CN1410126A Recombinant human interferon alpha nose drops and its production technology |
| 04/16/2003 | CN1410122A Chinese medicine preparation for treating acute condyloma |
| 04/16/2003 | CN1410119A Rhubarb ground beetle pill |
| 04/16/2003 | CN1410115A Capsule for treating coryza and its preparation method |
| 04/16/2003 | CN1410082A Bone strengthening pill and its preparation method |
| 04/16/2003 | CN1410079A Curcuma zedoary oil nano capsule freeze dried ampoule powder for injection and its preparation technology |
| 04/16/2003 | CN1410072A Sulfadiazine silver chitinamine powder |
| 04/16/2003 | CN1410071A Archimycin gel for eye application |
| 04/16/2003 | CN1410069A Broad spectrum anti bacterial traditional Chinese medicine and its preparation method |
| 04/16/2003 | CN1410062A Sodium rebeilazole for injection use |
| 04/16/2003 | CN1410060A 苦参碱阴道凝胶 Matrine vaginal gel |
| 04/16/2003 | CN1105725C Modulators for functions of FAS/APO1 receptors |
| 04/16/2003 | CN1105723C Spirocyclic metalloprotease inhibitors |
| 04/16/2003 | CN1105720C Imidazopyridazines compound |
| 04/16/2003 | CN1105715C New pyridonecarboxylic acid derivatives or their salts and antibacterial agent comprising same as active ingredient |
| 04/15/2003 | WO2002089822A1 Bactericidal disinfectant, antibacterial drug, and antibacterial material |
| 04/15/2003 | US6548671 Quinoxalinyl amide derivatives |
| 04/15/2003 | US6548668 Stabilizer for proteins |
| 04/15/2003 | US6548638 Peptoid and nonpeptoid containing α-keto oxadiazoles as serine protease inhibitors |
| 04/15/2003 | US6548631 Macrophage derived chemokine (MDC) as an anti-viral agent for the treatment and prevention of lentivirus infection |
| 04/15/2003 | US6548546 HIV integrase inhibitors |
| 04/15/2003 | US6548522 N-substituted 2,2-diphenylacetamide or N-substituted 2-phenyl-2-pyridinylacetamide |
| 04/15/2003 | US6548506 1-substituted,3-carboxy,7-fluoro,8-disubstituted amino-1,4-dihydrobenzo(b)(1,8)naphthyridin-4-ones; Useful as antimicrobial agents; topical antibiotic for wounds |
| 04/15/2003 | US6548503 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| 04/15/2003 | US6548500 Treating a cell adhesion-mediated diseases such as multiple sclerosis, asthma, atherosclerosis, rheumatoid arthritis, meningitis, comprising administering to a warm blooded animal a nitrogen atoms containing bicyclic compound |
| 04/15/2003 | US6548497 Methods of reducing non-inflammatory pain |
| 04/15/2003 | US6548492 Process for formulation of carbapenem antibiotic compositions |
| 04/15/2003 | US6548486 New viricide compounds of the general formula: Nu-O-Fa, wherein O represents an oxygen, Nu is a nucleoside or nucleoside analogue, and Fa is an acyl group of mono-unsaturated c18-c20 fatty acid |
| 04/15/2003 | US6548483 Nutritional preparation comprising ribose and medical use thereof |
| 04/15/2003 | US6548476 Dimeric inhibitors of influenza neuraminidase |
| 04/15/2003 | US6548295 Complex of lipo-viro-particles, method of preparation and applications |
| 04/15/2003 | US6548287 Non-pyrogenic bacterial strains and use of the same |
| 04/15/2003 | US6548281 Polypeptides, polynucleotides formed via recombination; for screening for antibacterial compounds |
| 04/15/2003 | US6548279 For polypeptides able to catalyze the enzymatic function of superoxide dismutase, carbonic anhydrase, or HIV protease |
| 04/15/2003 | US6548083 Prolonged release active agent dosage form adapted for gastric retention |
| 04/15/2003 | US6548079 Moxifloxacin formulation containing common salt |
| 04/15/2003 | US6548070 Attenuated strains of mycobacteria |
| 04/15/2003 | US6548068 Genetic engineered vaccine; gene coding antigen to disease and genetic engineerded viruses inserted into genome |
| 04/15/2003 | US6548055 Activation cell in immunology system |
| 04/15/2003 | CA2426096A1 Sterilizing disinfectant, antimicrobial agent and antimicrobial material |
| 04/15/2003 | CA2296466C Alatrofloxacin parenteral compositions |
| 04/15/2003 | CA2047375C Piperidyl ethers and thioethers as inhibitors of cholesterol biosynthesis |
| 04/10/2003 | WO2003029484A2 Antimicrobial methods and materials |
| 04/10/2003 | WO2003029475A1 MAMMALIAN CELL-INFECTING VIRUS VECTOR ENCODING EPITOPE-BOUND β2m AND UTILIZATION THEREOF |
| 04/10/2003 | WO2003029437A2 Secreted proteins |
| 04/10/2003 | WO2003029436A2 Ul16 binding protein 4 |
| 04/10/2003 | WO2003029433A2 Chimeric viral vectors for gene therapy |
| 04/10/2003 | WO2003029424A2 Novel proteins and nucleic acids encoding same |
| 04/10/2003 | WO2003029423A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/10/2003 | WO2003029410A2 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER |
| 04/10/2003 | WO2003029295A1 Human tissue factor antibodies |
| 04/10/2003 | WO2003029293A2 Modulators of notch ic protease activity for use in immunotherapy |